SynthesisDie Ophthalmologie2025
[Dietary supplements for dry eye disease].
Synthesis in Die Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDry eye disease is one of the most frequent surface diseases of the human eye. Although its etiology has not yet been established in detail, inflammatory components are increasingly considered as key factors in the development of the disease. Through inflammatory cascades stress at the ocular surface induces the release of reactive oxygen species (ROS), which additionally lead to oxidative stress. The end point of this cascade is the secretion of mediators of inflammation, which again release ROS. Corneal epithelial cells and goblet cells lose their integrity, further fueling tear film destabilization and ocular surface damage. AIM OF THE STUDY (OBJECTIVE): Various foodstuffs and nutrients are known for their antioxidative and/or anti-inflammatory characteristics, leading to an increasing interest of the role of nutritional supplements in the treatment of different diseases. This review summarizes dietary supplements that have shown positive effects on the ocular surface in dry eye disease in clinical studies. MATERIAL AND
methodsA systematic review was performed for studies published in English on the use of dietary supplements in the treatment of dry eye disease up to July 2025 analyzing quantitative or qualitative data. PubMed served as the database, the sub-items of the review (essential fatty acids, vitamins, trace elements, minerals, plant substances and probiotics) were used as keywords. The results included reflect the clinical relevance and application possibilities, which evaluated the impact of dietary supplements in the treatment of dry eye disease.
resultsThe most important nutrient categories associated with dry eye disease include essential fatty acids, vitamins, trace elements, minerals, phytochemicals, and probiotics. Oral supplementation has shown positive effects, although frequent blood count tests to determine levels are essential in cases of long-term use. Omega fatty acids are the most comprehensively studied dietary supplements with the highest rate of randomized controlled trials (evidence level 1).
conclusionNutritional dietary supplementation is promising but there is a need for further clinical research, especially regarding optimized supplement dosing and potential synergistic treatment effects in combination with conventional treatment methods.
Indexed as
Identifiers
41236576What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.